📈 SIBO – amikor a vastagbél baktériumai a vékonybélbe vándorolnak 🎈
#sibo #bakteriálistúlnövekedés #rifaximin #mmc #puffadás
#aradiágnes #komplementeroktatóközpont #természetgyógyászoktatás #természetgyógyászat #egészség
📽️ Now online 🎧: lnkd.in/dJuMmsc4
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
Recent study:⬆️ #daptomycin resist w #rifaximin.
But does this impact outcomes in #cirrhosis?
In VA & TriNetX we found no impact of rifaximin on dapt users on
🔑30-day mortality
🔑LT
🔑sepsis dev
🔑linezolid use
✅ @amergastroassn.bsky.social ➡️ pubmed.ncbi.nlm.nih.gov/40122471/ @absteward.bsky.social
Started #Rifaximin for my #SIBO & already feel a lot better ☺️
#MultipleSclerosis
#GutHealth
And in the news section we bring you the recent article by the labs of Benjamin Howden, @clairegorrie.bsky.social & Glen Carter at Uni of Melbourne featuring new findings on #rifaximin and #daptomycin resistance!
Don’t miss the episode 🤓
Read the original article here👇
doi.org/10.1038/s415...
#MedSky🧪#IDSky #Publichealth Study show that #rifaximin, an unrelated antibiotic used prophylactically to prevent #hepatic #encephalopathy in patients with liver disease, causes cross-resistance to #daptomycin in VREfm
www.nature.com/articles/s41...
🔍 Federal Circuit affirms Rifaximin patent rulings, ANDA approval restrictions upheld. Impact on Hatch-Waxman litigation precedents. #PatentLaw #HatchWaxman #FederalCircuit #Rifaximin http://dlvr.it/T7wpYn
@EASLedu @IsraelsenMads results of 18 mos. #Rifaximin vs. placebo RCT evaluating fibrosis in non sober alc hepatitis.
✅ 7 years to complete
✅ 21% drop out
✅ no effect on fibrosis reduction
✅reduction in fibrosis progression
✅ seems safe. No c diff
More Q Than A
#ILC2022
